115 related articles for article (PubMed ID: 17110903)
1. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort.
Bataille V; Perret B; Dallongeville J; Arveiler D; Yarnell J; Ducimetière P; Ferrières J
Diabetes Metab; 2006 Nov; 32(5 Pt 1):475-9. PubMed ID: 17110903
[TBL] [Abstract][Full Text] [Related]
2. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
[TBL] [Abstract][Full Text] [Related]
3. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
[TBL] [Abstract][Full Text] [Related]
4. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
[TBL] [Abstract][Full Text] [Related]
5. Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study.
Dauchet L; Ferrières J; Arveiler D; Yarnell JW; Gey F; Ducimetière P; Ruidavets JB; Haas B; Evans A; Bingham A; Amouyel P; Dallongeville J
Br J Nutr; 2004 Dec; 92(6):963-72. PubMed ID: 15613259
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
7. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
Zabetian A; Hadaegh F; Azizi F
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
[TBL] [Abstract][Full Text] [Related]
8. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Scarabin PY; Arveiler D; Amouyel P; Dos Santos C; Evans A; Luc G; Ferrières J; Juhan-Vague I;
Atherosclerosis; 2003 Jan; 166(1):103-9. PubMed ID: 12482556
[TBL] [Abstract][Full Text] [Related]
10. Physical activity and coronary event incidence in Northern Ireland and France: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Wagner A; Simon C; Evans A; Ferrières J; Montaye M; Ducimetière P; Arveiler D
Circulation; 2002 May; 105(19):2247-52. PubMed ID: 12010905
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Sattar N; Gaw A; Scherbakova O; Ford I; O'Reilly DS; Haffner SM; Isles C; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J
Circulation; 2003 Jul; 108(4):414-9. PubMed ID: 12860911
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and coronary heart disease risk in the PRIME study.
Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
Atherosclerosis; 2007 Mar; 191(1):90-7. PubMed ID: 16774755
[TBL] [Abstract][Full Text] [Related]
13. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study.
Lawlor DA; Smith GD; Ebrahim S
Diabetologia; 2006 Jan; 49(1):41-8. PubMed ID: 16378165
[TBL] [Abstract][Full Text] [Related]
14. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.
Hadaegh F; Zabetian A; Tohidi M; Ghasemi A; Sheikholeslami F; Azizi F
Ann Acad Med Singap; 2009 Feb; 38(2):142-9. PubMed ID: 19271043
[TBL] [Abstract][Full Text] [Related]
16. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
17. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction.
Yarnell JW
QJM; 1998 Oct; 91(10):667-76. PubMed ID: 10024924
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
20. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.
Ducimetière P; Ruidavets JB; Montaye M; Haas B; Yarnell J;
Int J Epidemiol; 2001 Oct; 30(5):1057-62. PubMed ID: 11689522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
